Tehran University of Medical Sciences

Science Communicator Platform

Share By
Coronavirus Disease 2019 (Covid-19): Immune Responses, Transmission, and Clinical Features: An Update Publisher



Hosseini P1 ; Dehghan A2 ; Navand AH3 ; Moghadami M4 ; Soltani S1, 6 ; Zandi M1, 6
Authors

Source: Journal of Cellular and Molecular Anesthesia Published:2020


Abstract

A novel beta-coronavirus was reported in Wuhan, Hubei Province, China, which in December 2019, which was named SARS-CoV-2. It causes Coronavirus Disease 2019 (COVID-19) that can affect lung tissue and airways. The immune system can respond to SARS-CoV-2 infection via various mechanisms. Cytokines play crucial roles in COVID-19. In the present study, the latest information on the immune responses, transmission, symptoms, diagnosis, and treatment of COVID-19 is reviewed. © 2020 Shahid Beheshti University of Medical Sciences, Anesthesiology Research Center. All right reserved.
Related Docs
View other Related Docs
1. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
2. Pathological Effects of Sars-Cov-2 on Hematological and Immunological Cells: Alterations in Count, Morphology, and Function, Pathology Research and Practice (2022)
3. Covid-19: A Trigger of Autoimmune Diseases, Cell Biology International (2023)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (4)
Farshid Noorbakhsh (1)
Other Related Docs
4. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
5. The Involvement of the Central Nervous System in Patients With Covid-19, Reviews in the Neurosciences (2020)
6. Immune Mechanisms in the Pathogenesis of Coronavirus Disease 2019, Journal of Cellular and Molecular Anesthesia (2022)
7. A Review on the Mechanisms Involved in the Immunopathogenesis of Sars-Cov-2, Journal of Military Medicine (2020)
8. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
9. Towards Treatment Planning of Covid-19: Rationale and Hypothesis for the Use of Multiple Immunosuppressive Agents: Anti-Antibodies, Immunoglobulins, and Corticosteroids, International Immunopharmacology (2020)
10. Covid-19: From the Molecular Mechanisms to Treatment, Tanaffos (2022)
11. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)
12. The Outlook for Diagnostic Purposes of the 2019-Novel Coronavirus Disease, Journal of Cellular Physiology (2020)
13. Pathogenesis, Clinical Manifestations and Complications of Coronavirus Disease 2019 (Covid-19), Future Microbiology (2020)
14. The Contributory Role of Lymphocyte Subsets, Pathophysiology of Lymphopenia and Its Implication As Prognostic and Therapeutic Opportunity in Covid-19, International Immunopharmacology (2021)
15. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
16. Extracorporeal Hemoperfusion As a Potential Therapeutic Option for Severe Covid-19 Patients; a Narrative Review, Archives of Academic Emergency Medicine (2020)
17. Immune Responses and Pathogenesis of Sars-Cov-2 During an Outbreak in Iran: Comparison With Sars and Mers, Reviews in Medical Virology (2020)
18. Dynamic Antibody Response: A Biomarker for Covid-19, Clinical Laboratory (2021)
19. Molecular Signaling Pathways, Pathophysiological Features in Various Organs, and Treatment Strategies in Sars-Cov2 Infection, Acta Histochemica (2022)
20. Host Factors: Implications in Immunopathogenesis of Covid-19, Pathology Research and Practice (2021)